Top advances of the year: Sarcoma

Cancer. 2025 Jul 1;131(13):e35965. doi: 10.1002/cncr.35965.

Authors

Mason Vierra¹, Jamie Brett², Jiping Wang¹

Affiliations

¹ Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
² Department of Medical Oncology, Dana-Farber/Mass General Brigham, Boston, Massachusetts, USA.

PMID: 40581846
DOI: 10.1002/cncr.35965

No abstract available

Keywords: afamitresgene autoleucel; immunotherapy; mesenchymal tumors; nirogacestat; pembrolizumab; sarcoma.